Ambarella [AMBA] vs Nova [NVMI] Detailed Stock Comparison

Ambarella

Nova
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Ambarella wins in 8 metrics, Nova wins in 10 metrics, with 0 ties. Nova appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | Ambarella | Nova | Better |
---|---|---|---|
P/E Ratio (TTM) | -29.63 | 43.69 | Ambarella |
Price-to-Book Ratio | 6.13 | 8.71 | Ambarella |
Debt-to-Equity Ratio | 0.60 | 19.08 | Ambarella |
PEG Ratio | 0.66 | 0.88 | Ambarella |
EV/EBITDA | -39.00 | 36.11 | Ambarella |
Profit Margin (TTM) | -25.46% | 29.10% | Nova |
Operating Margin (TTM) | -23.02% | 30.64% | Nova |
EBITDA Margin (TTM) | N/A | 30.64% | N/A |
Return on Equity | -15.77% | 24.23% | Nova |
Return on Assets (TTM) | -9.09% | 10.60% | Nova |
Free Cash Flow (TTM) | $23.46M | $218.05M | Nova |
1-Year Return | 43.01% | 52.88% | Nova |
Price-to-Sales Ratio (TTM) | 10.32 | 11.83 | Ambarella |
Enterprise Value | $3.33B | $9.20B | Nova |
EV/Revenue Ratio | 9.58 | 11.40 | Ambarella |
Gross Profit Margin (TTM) | 58.87% | 57.84% | Ambarella |
Revenue per Share (TTM) | $8 | $28 | Nova |
Earnings per Share (Diluted) | $-2.11 | $7.37 | Nova |
Beta (Stock Volatility) | 2.10 | 1.75 | Nova |
Ambarella vs Nova Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Ambarella | 1.34% | 2.97% | 1.55% | 30.07% | 104.68% | 15.10% |
Nova | 2.78% | 6.39% | 21.00% | 15.57% | 94.00% | 63.18% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Ambarella | 43.01% | 72.62% | 49.47% | 51.25% | 1,269.02% | 1,269.02% |
Nova | 52.88% | 371.15% | 486.12% | 3,085.56% | 5,528.91% | 13,984.26% |
News Based Sentiment: Ambarella vs Nova
Ambarella
News based Sentiment: POSITIVE
Ambarella is making significant investments in a high-growth market (Edge AI) and is attracting increasing investor attention. While the stock appears overvalued based on one model, strong earnings expectations and analyst targets suggest continued positive momentum, making this a noteworthy month for investors.
Nova
News based Sentiment: POSITIVE
October proved to be a strong month for Nova Limited, driven by a significant earnings beat, optimistic guidance, and a new all-time high stock price. While some insider selling and minor stock dips occurred, the overall narrative points to continued growth and investor confidence in the company's future prospects.
Performance & Financial Health Analysis: Ambarella vs Nova
Metric | AMBA | NVMI |
---|---|---|
Market Information | ||
Market Cap | $3.62B | $9.55B |
Market Cap Category | Mid cap | Mid cap |
10 Day Avg. Volume | 555,360 | 317,011 |
90 Day Avg. Volume | 1,043,797 | 522,924 |
Last Close | $85.29 | $330.98 |
52 Week Range | $38.86 - $93.44 | $154.00 - $336.96 |
% from 52W High | -8.72% | -1.77% |
All-Time High | $227.59 (Nov 29, 2021) | $336.96 (Oct 06, 2025) |
% from All-Time High | -62.52% | -1.77% |
Growth Metrics | ||
Quarterly Revenue Growth | 0.50% | 0.40% |
Quarterly Earnings Growth | 0.50% | 0.51% |
Financial Health | ||
Profit Margin (TTM) | -0.25% | 0.29% |
Operating Margin (TTM) | -0.23% | 0.31% |
Return on Equity (TTM) | -0.16% | 0.24% |
Debt to Equity (MRQ) | 0.60 | 19.08 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | $13.74 | $36.98 |
Cash per Share (MRQ) | $6.12 | $18.78 |
Operating Cash Flow (TTM) | $52.36M | $229.71M |
Levered Free Cash Flow (TTM) | $68.89M | $140.87M |
Dividends | ||
Last 12-Month Dividend Yield | N/A | N/A |
Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Ambarella vs Nova
Metric | AMBA | NVMI |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | -29.63 | 43.69 |
Forward P/E | -467.56 | 42.71 |
PEG Ratio | 0.66 | 0.88 |
Price to Sales (TTM) | 10.32 | 11.83 |
Price to Book (MRQ) | 6.13 | 8.71 |
Market Capitalization | ||
Market Capitalization | $3.62B | $9.55B |
Enterprise Value | $3.33B | $9.20B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 9.58 | 11.40 |
Enterprise to EBITDA | -39.00 | 36.11 |
Risk & Other Metrics | ||
Beta | 2.10 | 1.75 |
Book Value per Share (MRQ) | $13.74 | $36.98 |
Financial Statements Comparison: Ambarella vs Nova
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | AMBA | NVMI |
---|---|---|
Revenue/Sales | $85.87M | $213.36M |
Cost of Goods Sold | $34.34M | $91.05M |
Gross Profit | $51.54M | $122.30M |
Research & Development | $58.82M | $33.23M |
Operating Income (EBIT) | $-25.86M | $63.23M |
EBITDA | $-19.11M | $68.13M |
Pre-Tax Income | $-23.68M | $76.17M |
Income Tax | $645,000 | $11.35M |
Net Income (Profit) | $-24.33M | $64.82M |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | AMBA | NVMI |
---|---|---|
Cash & Equivalents | $141.29M | $141.06M |
Total Current Assets | $335.55M | $875.74M |
Total Current Liabilities | $124.85M | $401.78M |
Long-Term Debt | $2.06M | $47.66M |
Total Shareholders Equity | $572.72M | $982.12M |
Retained Earnings | $-276.39M | N/A |
Property, Plant & Equipment | $13.06M | $139.85M |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | AMBA | NVMI |
---|---|---|
Operating Cash Flow | $15.43M | $73.99M |
Capital Expenditures | $-4.57M | $-8.86M |
Free Cash Flow | $10.24M | $59.69M |
Debt Repayment | N/A | N/A |
Common Stock Repurchase | $-1.00M | $-20.00M |
Short Interest & Institutional Ownership Analysis
Metric | AMBA | NVMI |
---|---|---|
Shares Short | 1.97M | 1.64M |
Short Ratio | 1.82 | 3.47 |
Short % of Float | 0.05% | 0.06% |
Average Daily Volume (10 Day) | 555,360 | 317,011 |
Average Daily Volume (90 Day) | 1,043,797 | 522,924 |
Shares Outstanding | 41.96M | 29.28M |
Float Shares | 40.16M | 29.61M |
% Held by Insiders | 0.05% | 0.00% |
% Held by Institutions | 0.86% | 0.77% |
Dividend Analysis & Yield Comparison: Ambarella vs Nova
Metric | AMBA | NVMI |
---|---|---|
Last 12-Month Dividend | N/A | N/A |
Last 12-Month Dividend Yield | N/A | N/A |
3-Year Avg Annual Dividend | N/A | N/A |
3-Year Avg Dividend Yield | N/A | N/A |
3-Year Total Dividends | N/A | N/A |
Ex-Dividend Date | N/A | N/A |